Cite Filings / AVIR / 0000950170-24-068683

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Atea Pharmaceuticals, Inc. Filed 2024-06-04 Acc 0000950170-24-068683

Documents 1

DEFA14A Proxy Materials , avir-defa_14a_2024_proxy.htm

Around this filing

2025-03-24 DEFA14A Proxy Materials
2024-06-07 4 President, CEO, and Chairman sold 1,006 shares at $4.00 ($4,024)
2024-06-05 144 Sale of Securities
2024-06-04 DEFA14A Proxy Materials
2024-04-26 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading avir-defa_14a_2024_proxy.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…